Results 161 to 170 of about 4,714 (209)

Impact of serum luteinizing hormone level and increment on the day of endometrial transformation on frozen-thawed single blastocyst transfer outcome in the hormone replacement cycle. [PDF]

J Ovarian Res
Yu K, Zhou J, Ju J, Han A.
europepmc   +1 more source

Progestin-primed ovarian stimulation protocol in patients undergoing assisted reproductive technology. [PDF]

Front Reprod Health
Qi S, Yu H, Yang X, Shi Q, Yang L, Wang K.   +5 more
europepmc   +1 more source

Vaginal micronized progesterone on preventing luteinizing hormone untimely surge in ART cycles: A prospective proof-of-concept study. [PDF]

JBRA Assist Reprod
Souza MDCB, Antunes RA, Souza MM, Mancebo ACA, Barbeitas AL, Raupp VA, Rebello DM.   +6 more
europepmc   +1 more source

Comparative Effectiveness of Tibolone and Combined Hormone Therapy in Relieving Menopausal Insomnia. [PDF]

Womens Health Rep (New Rochelle)
Song Z, Li C, Jin F, Sun D, Tao M.
europepmc   +1 more source

Miten löytää endometrioosi? [PDF]

Savolainen, Leena
core  

Some of the next articles are maybe not open access.

Related searches:

Dydrogesterone: Metabolism in man

European Journal of Drug Metabolism and Pharmacokinetics, 1980
An investigation of the urinary metabolites of the oral progestational agent dydrogesterone in healthy women of childbearing age is reported. The drug was administered in 3H-labelled form and the urine of the first 8 h, containing on average 38% of the radioactivity administered, was used as the source of the metabolites.
P H, van Amsterdam, H, Overmars, P M, Scherpenisse, H, de Bree   +3 more
openaire   +2 more sources

Dydrogesterone: metabolism in animals

European Journal of Drug Metabolism and Pharmacokinetics, 1983
The metabolic pattern of dydrogesterone was investigated in the rat, dog, mouse, rabbit and rhesus monkey. The drug was administered orally in 3H-labelled form. Following enzymatic hydrolysis of conjugates the radioactive metabolites were extracted from the urine, and in rat and dog also from bile.
H, de Bree, D J, van der Stel, N, de Lange, L C, Post   +3 more
openaire   +2 more sources

Dydrogesterone support in threatened miscarriage

Maturitas, 2009
The aim of this study was to determine whether dydrogesterone helps to preserve pregnancy in women with threatened miscarriage.146 women who presented with mild or moderate vaginal bleeding during the first trimester of pregnancy were randomised to receive oral dydrogesterone (10mg b.i.d.) (n=86) or no treatment (n=60).
Mazen Y, El-Zibdeh, Lama T, Yousef
openaire   +2 more sources

DYDROGESTERONE AND ENDOMETRIOSIS

BJOG: An International Journal of Obstetrics & Gynaecology, 1976
SummaryThe results are reported of the administration of dydrogesterone, 5 mg twice daily, to 49 patients with endometriosis. All but five patients were symptom‐free after nine months of therapy. Most subjective symptoms had disappeared within four to eight weeks; dyspareunia usually took longer.
openaire   +2 more sources